1. Home
  2. CDNA vs HLF Comparison

CDNA vs HLF Comparison

Compare CDNA & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • HLF
  • Stock Information
  • Founded
  • CDNA 1998
  • HLF 1980
  • Country
  • CDNA United States
  • HLF United States
  • Employees
  • CDNA N/A
  • HLF N/A
  • Industry
  • CDNA Medical Specialities
  • HLF Other Pharmaceuticals
  • Sector
  • CDNA Health Care
  • HLF Health Care
  • Exchange
  • CDNA Nasdaq
  • HLF Nasdaq
  • Market Cap
  • CDNA 712.2M
  • HLF 854.5M
  • IPO Year
  • CDNA 2014
  • HLF N/A
  • Fundamental
  • Price
  • CDNA $11.84
  • HLF $9.62
  • Analyst Decision
  • CDNA Buy
  • HLF Strong Buy
  • Analyst Count
  • CDNA 6
  • HLF 4
  • Target Price
  • CDNA $27.67
  • HLF $11.50
  • AVG Volume (30 Days)
  • CDNA 1.5M
  • HLF 2.1M
  • Earning Date
  • CDNA 08-06-2025
  • HLF 08-06-2025
  • Dividend Yield
  • CDNA N/A
  • HLF N/A
  • EPS Growth
  • CDNA N/A
  • HLF 285.96
  • EPS
  • CDNA 1.00
  • HLF 3.17
  • Revenue
  • CDNA $340,826,000.00
  • HLF $4,928,500,000.00
  • Revenue This Year
  • CDNA $12.81
  • HLF $0.40
  • Revenue Next Year
  • CDNA $13.36
  • HLF $4.25
  • P/E Ratio
  • CDNA $11.87
  • HLF $3.03
  • Revenue Growth
  • CDNA 14.72
  • HLF N/A
  • 52 Week Low
  • CDNA $10.96
  • HLF $5.04
  • 52 Week High
  • CDNA $34.84
  • HLF $10.83
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 33.98
  • HLF 54.35
  • Support Level
  • CDNA $11.73
  • HLF $8.85
  • Resistance Level
  • CDNA $12.76
  • HLF $9.80
  • Average True Range (ATR)
  • CDNA 0.64
  • HLF 0.49
  • MACD
  • CDNA 0.13
  • HLF -0.01
  • Stochastic Oscillator
  • CDNA 28.61
  • HLF 87.06

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About HLF Herbalife Ltd.

Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.

Share on Social Networks: